"Next-Generation Technology Solution"

A New Generation of Controlled Release Insulin with a Non-Invasive & Cost-Effective
Real-Time Glucose Monitoring Nano-Sensor

About Us

Jelin Frontier Technologies will offer an advanced monitoring solution, transforming the medical diagnosis world. The next-generation technology solution will help in solving the current pain points of diabetic patients. The Company will be a provider of technology of controlled release insulin with a non-invasive & cost-effective real-time glucose monitoring nanosensor.

Vision

To revolutionize the existing glycemic level monitoring and insulin therapy system by leveraging nanotechnology, thereby improving the lives of the patients as well as the caregivers.

Mission

To leverage data and smart technology and create smart, automated healthcare solutions with the aim to minimize the complications and lead to better outcomes for people with diabetes.

What We Do

Bringing diabetic patients a non-invasive and cost-effective Continuous Glucose Monitoring solution. This technology solution will help in solving some of the biggest issues that many diabetics have.

dot-4.png
"Highly Accurate & Precise"

Problems To Solve

Managing and monitoring blood sugar levels can reduce the risk of future complications. Due to pain and inconvenience caused by finger pricking, many patients feel reluctant to perform frequent self-monitoring of blood glucose levels.

The excess use of insulin injections causes skin problems, such as hypertrophy, at injection sites. Moreover, many people with a regular infusion of injections are facing fat necrosis. This causes an injury to an area of fatty tissue thus, impacting the fat cells to a greater extent.

Sensitivity of insulin dosage is a significant issue, as a single dose of insulin depends on various factors such as time of the day, sensitivity to insulin, the planned activity of the day, and the patient’s insulin resistance levels. According to research, around 60% of patients with diabetes miss their injections, with 20% missing doses regularly. This has increased complications for the patients, degrading their recovery procedures.

Our Products

Nano-Sensor for Real-time BG Monitoring and Mobile Application for Tracking the Concentration

  • High accuracy in glucose detection (>95%)
  • Highly reduced invasiveness
  • No loss of accuracy with time
  • Smart control of glucose concentration
  • Minimizing the human error
  • A realistic analysis of the recorded data

Insulin Loaded Nanoparticles
for a Controlled Release

  • Easily scalable method
  • Excellent controlled release behavior
  • Highly reduced number of injections
  • Insulin loaded nanoparticles for a controlled release
  • Reduction of dosage & timing errors
  • Improved life quality of diabetic patients

Our Solution

Solution 1

To eradicate the pain and fear from finger pricking and to have more accurate results, Jelin's solution includes a needle-like sensor. The sensor will be placed under the skin to measure glucose levels continuously. The Company has developed a non-invasive, painless and accurate way to monitor the blood glucose levels day and night, on a regular basis.

Solution 2

To curb the problem of multiple injections, the company will provide a solution that will control insulin release in the patient's body through nanoparticles. A biodegradable glucose-responsive polymeric matrix will encapsulate the insulin and, a microfluidic system will produce the insulin-loaded nanoparticles. Thus, using this solution, patients can keep their glucose levels in control for about 100 hours, with only a single injection.

Solution 3

For regular monitoring and analysis of the blood glucose levels and sending alerts to the patient for timely delivery of insulin injections, the company has developed a mobile application. The mobile application will receive accurate information from the nanosensors, help track the blood glucose levels, and alert the patient/caretaker/doctor when the insulin level drops below a specified measure.

Solution 4

The mobile application will also alert the patient when the effect of the administered injection diminishes. The application will use a freemium model where the users will access several premium features on paying a basic subscription fee.

Our Advantages

Non-Invasive Glucose Monitoring

Enhanced Control Over Blood Glucose Levels

Cost-Effective

Fast, Proactive Response and
Easy Management

ISF as the Glucose
Detection Source

How It Works

1

A needle-like nano-sensor will be placed on the skin of the user, which will continuously note the readings from the glucose present in interstitial fluid (ISF).

2

The transmitter attached to the sensor will send the data to the mobile device.

3

A mobile application will be installed on the device, which will display a graph of changing sugar levels on the screen.

4

Based on the received glucose levels and alerts shared by the application, the caretakers/doctors can infuse the next dose of insulin. Further, this nanoparticle infused.

Our Testimonials

"Super Useful and Best Innovation"
Jan Masters
Patient
"Highly Recommended"
Jane Wilcox
Patient
"Great Product for Diabetic Patients"
Dan Ellis
Patient

Meet The Team

Sara Kaveh

Chief Executive Officer

She has over 12 years of experience as a well-rounded professional with sound business and financial acumen. She had worked as Researcher and Quality Control Manager. As Chief Executive Officer of Jelin Frontier Technologies, she hopes to utilize her prior experience to satisfy both short and long-term company objectives and capitalize on any new business opportunities. Her extensive leadership skills ensure the success of Jelin Frontier Technologies in the Canadian market.

Bijan Maghsoodlou

Chief Medical Officer

He is a medical professional with 14 years of experience effectively treating patients with a wide range of conditions. He had worked as a Family Physician/ General Practitioner, Psychiatrist Specialized Assistant, Psychiatrist/ Technical Manager. As Chief Medical Officer of Jelin Frontier Technologies, his eagerness to excel and his in-depth medical knowledge will be vital for the company’s ability to thrive in Canada.

Anna Dehmolaeian

Chief Technology Officer

She is a proven leader with over 5 years of experience. She had worked as Project Manager. As Chief Technology Officer of Jelin Frontier Technologies, her ability to build strong interpersonal relationships with excellent analytical and time-management skills would ensure the technology used is of the highest standard and is continuously upgraded as per the market demand and latest trends. She would oversee implementing new technology into the company, ensuring the tech advantage for Jelin Frontier Technologies in the market.

Mehdi Hatamiaghdam

Chief Operations Officer

He is a well-established and dynamic leader in the industry with over 19 years of experience. He had worked as a Sales Manager and Member of Board of Directors. As Chief Operations Officer of Jelin Frontier Technologies, Mr. Mehdi Hatamiaghdam’s in-depth knowledge in areas of business strategy and development will support and provide leadership, thought partnership, and tactical support to the people of Jelin Frontier Technologies, its effectiveness, and finance teams, ensuring that all the systems, policies, and practices reflect its core values and its ability to thrive in Canada.

Our Blogs

Newsletter Subscription

Don’t miss our future updates! Get Subscribed Today!

Scroll to Top